Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 90Lung Neoplasms 34Meningeal Carcinomatosis 11Neoplasms 9Neoplasm Metastasis 7Adenocarcinoma of Lung 6Colorectal Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Mesothelioma, Malignant 4Non-squamous Non-small Cell Lung Cancer 3NSCLC 3Mesothelioma 3Carcinoma 3Advanced Solid Tumors 3Non Squamous Non Small Cell Lung Cancer 2Neoplasms by Site 2Neoplasms by Histologic Type 2Carcinoma, Bronchogenic 2Bronchial Neoplasms 2Breast Neoplasms 2Vaccinia 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Small Cell Lung Carcinoma 1Sexual Dysfunction, Physiological 1Sarcoma, Ewing 1Sarcoma 1

Interventions

pembrolizumab 1Saline Solution 1Pemetrexed 1Nivolumab 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Metastatic Non-Squamous Non-Small Cell Lung Cancer × Pemetrexed × Clear all
NCT07098988 2026-05-13

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

CatalYm GmbH

Phase 2 Recruiting
107 enrolled
Other solid neoplasmThoracic

Metastatic Non-Squamous Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡